|
|
|
| home > ebr > summer 2003 > biotechnology: breathing new life into drug development |
|
|
 PUBLICATIONS |
European Biopharmaceutical Review
|
| As the environment in which they operate becomes more competitive, pharmaceutical companies are finding it increasingly difficult to boost the output of new drugs. In recent years, some of the major companies in the industry have received criticism from those who believe that they lack new ideas and methodologies. They assert that the industry is producing too many new drugs that are similar to each other and offer little clinical advantage over those already on the global market. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By Faiz Kermani, Budgets, Proposals and Marketing Executive, and Pietro Bonacossa, Marketing Executive, at Chiltern International, Inc
Dr Faiz Kermani is currently a Budgets, Proposals & Marketing Executive working in business development at Chiltern International. He previously worked in business development at CMR International, examining R&D productivity issues for pharmaceutical industry clients.
He holds a PhD in Immunopharmacology from St Thomas' Hospital, London and a First Class honours degree in Pharmacology with Toxicology from King's College, London.
Pietro Bonacossa is a Marketing Executive at Chiltern International in the USA. He holds a BA degree in International Trade from Auburn University and an MBA in Marketing from Georgia State University.
Prior to joining Chiltern, he spent two years at Turner Broadcasting Systems, working as a Project Co-ordinator for CNN Headline News and as a Public Relations Liaison for CNN.com.
|
|
|
|
|
|
 |
Industry Events |
 |
5th Annual BioPharma Asia Convention 2012
19-22 March 2012, Marina Bay Sands, Singapore
BioPharma Asia Convention is the only event that brings together senior level executives from global and regional pharma companies, biotechs, CMOs, CROs, academic institutions, investors and all other industrial stakeholders to assess the latest industrial trends, partnership models and solutions in Asia.
More info >> |
|
 |
News and Press Releases |
 |
More safety in drug packaging
In Germany like in the rest of the world, child safety in drug packaging is an issue that has not been properly solved yet. Today, Faubel, the custom label supplier based in Melsungen, provides a safe and economical solution consisting of an innovative safety label which can be affixed to the back of a tablet blister pack like an ordinary sticker.
More info >> |
|
|
